Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant "passive" short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.
This report elaborates on the current development of the Hyperimmune Globulins industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
CNBG
Emergent (Cangene)
Shanghai RAAS
Hualan Bio
CBPO
ADMA Biologics
Biotest
Sichuan Yuanda Shuyang
CSL Behring
Grifols
By Type:
Hepatitis B Immunoglobulins
Rabies Immunoglobulins
Tetanus Immunoglobulins
Others
By Application:
Private Sector
Government Institutions
Other
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Hyperimmune Globulins Market Overview 2018-2029
-
1.1 China Hyperimmune Globulins Industry Development Overview
-
1.2 China Hyperimmune Globulins Industry Development History
-
1.3 China Hyperimmune Globulins Industry Market Size (2018-2029)
-
1.4 China Hyperimmune Globulins Market Analysis by Type from Production Side
-
1.4.1 China Hyperimmune Globulins Production Volume, Production Value and Growth Rate of Hepatitis B Immunoglobulins (2018-2029)
-
1.4.2 China Hyperimmune Globulins Production Volume, Production Value and Growth Rate of Rabies Immunoglobulins (2018-2029)
-
1.4.3 China Hyperimmune Globulins Production Volume, Production Value and Growth Rate of Tetanus Immunoglobulins (2018-2029)
-
1.4.4 China Hyperimmune Globulins Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
1.5 China Hyperimmune Globulins Market Analysis by Application from Consumption End
-
1.5.1 China Hyperimmune Globulins Sales Volume, Sales Value and Growth Rate of Private Sector (2018-2029)
-
1.5.2 China Hyperimmune Globulins Sales Volume, Sales Value and Growth Rate of Government Institutions (2018-2029)
-
1.5.3 China Hyperimmune Globulins Sales Volume, Sales Value and Growth Rate of Other (2018-2029)
-
1.6 China Hyperimmune Globulins Market Analysis by Region
-
1.6.1 North China Hyperimmune Globulins Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Hyperimmune Globulins Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Hyperimmune Globulins Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Hyperimmune Globulins Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Hyperimmune Globulins Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Hyperimmune Globulins Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Hyperimmune Globulins Market Size and Growth Rate from 2018-2029
Chapter 2 China Hyperimmune Globulins Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Hyperimmune Globulins Market Status and Competition at home and abroad in 2023
-
2.2.2 China Hyperimmune Globulins Market Status and Competition Analysis in 2023
-
2.2.3 China Hyperimmune Globulins Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Hyperimmune Globulins Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Hyperimmune Globulins Industry Development
Chapter 3 Hyperimmune GlobulinsIndustry Chain Analysis
-
3.1 Hyperimmune Globulins Industry Chain
-
3.2 Hyperimmune Globulins Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Hyperimmune Globulins Market
-
3.3 Hyperimmune Globulins Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Hyperimmune Globulins Market
Chapter 4 China Hyperimmune Globulins Market, by Type
-
4.1 China Hyperimmune Globulins Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Hyperimmune Globulins Total Production Volume and Growth Rate from Production Side
-
4.5 China Hyperimmune Globulins Production Volume and Growth Rate, by Type
-
4.5.1 China Hyperimmune Globulins Production Volume and Growth Rate of Hepatitis B Immunoglobulins
-
4.5.2 China Hyperimmune Globulins Production Volume and Growth Rate of Rabies Immunoglobulins
-
4.5.3 China Hyperimmune Globulins Production Volume and Growth Rate of Tetanus Immunoglobulins
-
4.5.4 China Hyperimmune Globulins Production Volume and Growth Rate of Others
Chapter 5 China Hyperimmune Globulins Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Hyperimmune Globulins Total Market Size and Growth Rate from Consumption End
-
5.5 China Hyperimmune Globulins Market Size and Growth Rate, by Application
-
5.5.1 China Hyperimmune Globulins Market Size and Growth Rate of Private Sector
-
5.5.2 China Hyperimmune Globulins Market Size and Growth Rate of Government Institutions
-
5.5.3 China Hyperimmune Globulins Market Size and Growth Rate of Other
Chapter 6 China Hyperimmune Globulins Market, by Region
-
6.1 China Hyperimmune Globulins Production Volume and Production Value, by Region
-
6.2 China Hyperimmune Globulins Sales Volume and Sales Value, by Region
Chapter 7 North China Hyperimmune Globulins Market Analysis
-
7.1 North China Hyperimmune Globulins Market, by Type
-
7.2 North China Hyperimmune Globulins Market, by Application
Chapter 8 Central China Hyperimmune Globulins Market Analysis
-
8.1 Central China Hyperimmune Globulins Market, by Type
-
8.2 Central China Hyperimmune Globulins Market, by Application
Chapter 9 South China Hyperimmune Globulins Market Analysis
-
9.1 South China Hyperimmune Globulins Market, by Type
-
9.2 South China Hyperimmune Globulins Market, by Application
Chapter 10 East China Hyperimmune Globulins Market Analysis
-
10.1 East China Hyperimmune Globulins Market, by Type
-
10.2 East China Hyperimmune Globulins Market, by Application
Chapter 11 Northeast China Hyperimmune Globulins Market Analysis
-
11.1 Northeast China Hyperimmune Globulins Market, by Type
-
11.2 Northeast China Hyperimmune Globulins Market, by Application
Chapter 12 Southwest China Hyperimmune Globulins Market Analysis
-
12.1 Southwest China Hyperimmune Globulins Market, by Type
-
12.2 Southwest China Hyperimmune Globulins Market, by Application
Chapter 13 Northwest China Hyperimmune Globulins Market Analysis
-
13.1 Northwest China Hyperimmune Globulins Market, by Type
-
13.2 Northwest China Hyperimmune Globulins Market, by Application
Chapter 14 Company Profiles
-
14.1 CNBG
-
14.1.1 CNBG Company Profile
-
14.1.2 CNBG Hyperimmune Globulins Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Emergent (Cangene)
-
14.2.1 Emergent (Cangene) Company Profile
-
14.2.2 Emergent (Cangene) Hyperimmune Globulins Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Shanghai RAAS
-
14.3.1 Shanghai RAAS Company Profile
-
14.3.2 Shanghai RAAS Hyperimmune Globulins Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Hualan Bio
-
14.4.1 Hualan Bio Company Profile
-
14.4.2 Hualan Bio Hyperimmune Globulins Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 CBPO
-
14.5.1 CBPO Company Profile
-
14.5.2 CBPO Hyperimmune Globulins Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 ADMA Biologics
-
14.6.1 ADMA Biologics Company Profile
-
14.6.2 ADMA Biologics Hyperimmune Globulins Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Biotest
-
14.7.1 Biotest Company Profile
-
14.7.2 Biotest Hyperimmune Globulins Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Sichuan Yuanda Shuyang
-
14.8.1 Sichuan Yuanda Shuyang Company Profile
-
14.8.2 Sichuan Yuanda Shuyang Hyperimmune Globulins Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 CSL Behring
-
14.9.1 CSL Behring Company Profile
-
14.9.2 CSL Behring Hyperimmune Globulins Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Grifols
-
14.10.1 Grifols Company Profile
-
14.10.2 Grifols Hyperimmune Globulins Market Performance
-
14.10.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Hyperimmune Globulins Industry Research Conclusions
-
15.2 Hyperimmune Globulins Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Hyperimmune Globulins Industry Market Size (2018-2029)
-
Figure China Hyperimmune Globulins Production Volume, Production Value and Growth Rate of Hepatitis B Immunoglobulins (2018-2029)
-
Figure China Hyperimmune Globulins Production Volume, Production Value and Growth Rate of Rabies Immunoglobulins (2018-2029)
-
Figure China Hyperimmune Globulins Production Volume, Production Value and Growth Rate of Tetanus Immunoglobulins (2018-2029)
-
Figure China Hyperimmune Globulins Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
Figure China Hyperimmune Globulins Sales Volume, Sales Value and Growth Rate of Private Sector (2018-2029)
-
Figure China Hyperimmune Globulins Sales Volume, Sales Value and Growth Rate of Government Institutions (2018-2029)
-
Figure China Hyperimmune Globulins Sales Volume, Sales Value and Growth Rate of Other (2018-2029)
-
Figure North China Hyperimmune Globulins Market Size and Growth Rate from 2018-2029
-
Figure Central China Hyperimmune Globulins Market Size and Growth Rate from 2018-2029
-
Figure South China Hyperimmune Globulins Market Size and Growth Rate from 2018-2029
-
Figure East China Hyperimmune Globulins Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Hyperimmune Globulins Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Hyperimmune Globulins Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Hyperimmune Globulins Market Size and Growth Rate from 2018-2029
-
Figure Hyperimmune Globulins Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Hyperimmune Globulins Market Share by Type in 2018
-
Figure China Hyperimmune Globulins Market Share by Type in 2023
-
Figure China Hyperimmune Globulins Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Hyperimmune Globulins Production Volume and Growth Rate of Hepatitis B Immunoglobulins (2018-2023)
-
Figure China Hyperimmune Globulins Production Volume and Growth Rate of Rabies Immunoglobulins (2018-2023)
-
Figure China Hyperimmune Globulins Production Volume and Growth Rate of Tetanus Immunoglobulins (2018-2023)
-
Figure China Hyperimmune Globulins Production Volume and Growth Rate of Others (2018-2023)
-
Figure China Hyperimmune Globulins Market Share by Application in 2018
-
Figure China Hyperimmune Globulins Market Share by Application in 2023
-
Figure China Hyperimmune Globulins Total Market Size and Growth Rate from Consumption End
-
Figure China Hyperimmune Globulins Market Size and Growth Rate of Private Sector (2018-2023)
-
Figure China Hyperimmune Globulins Market Size and Growth Rate of Government Institutions (2018-2023)
-
Figure China Hyperimmune Globulins Market Size and Growth Rate of Other (2018-2023)
-
Table China Hyperimmune Globulins Production Volume by Region (2018-2023)
-
Table China Hyperimmune Globulins Production Volume Share by Region (2018-2023)
-
Figure China Hyperimmune Globulins Production Volume Share by Region (2018-2023)
-
Table China Hyperimmune Globulins Production Value by Region (2018-2023)
-
Table China Hyperimmune Globulins Production Value Share by Region (2018-2023)
-
Figure China Hyperimmune Globulins Production Value Share by Region (2018-2023)
-
Table China Hyperimmune Globulins Sales Volume by Region (2018-2023)
-
Table China Hyperimmune Globulins Sales Volume Share by Region (2018-2023)
-
Figure China Hyperimmune Globulins Sales Volume Share by Region (2018-2023)
-
Table China Hyperimmune Globulins Sales Value by Region (2018-2023)
-
Table China Hyperimmune Globulins Sales Value Share by Region (2018-2023)
-
Figure China Hyperimmune Globulins Sales Value Share by Region (2018-2023)
-
Table North China Hyperimmune Globulins Production Volume by Type (2018-2023)
-
Table North China Hyperimmune Globulins Production Volume Share by Type (2018-2023)
-
Figure North China Hyperimmune Globulins Production Volume Share by Type (2018-2023)
-
Table North China Hyperimmune Globulins Sales Volume by Application (2018-2023)
-
Table North China Hyperimmune Globulins Sales Volume Share by Application (2018-2023)
-
Figure North China Hyperimmune Globulins Sales Volume Share by Application (2018-2023)
-
Table Central China Hyperimmune Globulins Production Volume by Type (2018-2023)
-
Table Central China Hyperimmune Globulins Production Volume Share by Type (2018-2023)
-
Figure Central China Hyperimmune Globulins Production Volume Share by Type (2018-2023)
-
Table Central China Hyperimmune Globulins Sales Volume by Application (2018-2023)
-
Table Central China Hyperimmune Globulins Sales Volume Share by Application (2018-2023)
-
Figure Central China Hyperimmune Globulins Sales Volume Share by Application (2018-2023)
-
Table South China Hyperimmune Globulins Production Volume by Type (2018-2023)
-
Table South China Hyperimmune Globulins Production Volume Share by Type (2018-2023)
-
Figure South China Hyperimmune Globulins Production Volume Share by Type (2018-2023)
-
Table South China Hyperimmune Globulins Sales Volume by Application (2018-2023)
-
Table South China Hyperimmune Globulins Sales Volume Share by Application (2018-2023)
-
Figure South China Hyperimmune Globulins Sales Volume Share by Application (2018-2023)
-
Table East China Hyperimmune Globulins Production Volume by Type (2018-2023)
-
Table East China Hyperimmune Globulins Production Volume Share by Type (2018-2023)
-
Figure East China Hyperimmune Globulins Production Volume Share by Type (2018-2023)
-
Table East China Hyperimmune Globulins Sales Volume by Application (2018-2023)
-
Table East China Hyperimmune Globulins Sales Volume Share by Application (2018-2023)
-
Figure East China Hyperimmune Globulins Sales Volume Share by Application (2018-2023)
-
Table Northeast China Hyperimmune Globulins Production Volume by Type (2018-2023)
-
Table Northeast China Hyperimmune Globulins Production Volume Share by Type (2018-2023)
-
Figure Northeast China Hyperimmune Globulins Production Volume Share by Type (2018-2023)
-
Table Northeast China Hyperimmune Globulins Sales Volume by Application (2018-2023)
-
Table Northeast China Hyperimmune Globulins Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Hyperimmune Globulins Sales Volume Share by Application (2018-2023)
-
Table Southwest China Hyperimmune Globulins Production Volume by Type (2018-2023)
-
Table Southwest China Hyperimmune Globulins Production Volume Share by Type (2018-2023)
-
Figure Southwest China Hyperimmune Globulins Production Volume Share by Type (2018-2023)
-
Table Southwest China Hyperimmune Globulins Sales Volume by Application (2018-2023)
-
Table Southwest China Hyperimmune Globulins Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Hyperimmune Globulins Sales Volume Share by Application (2018-2023)
-
Table Northwest China Hyperimmune Globulins Production Volume by Type (2018-2023)
-
Table Northwest China Hyperimmune Globulins Production Volume Share by Type (2018-2023)
-
Figure Northwest China Hyperimmune Globulins Production Volume Share by Type (2018-2023)
-
Table Northwest China Hyperimmune Globulins Sales Volume by Application (2018-2023)
-
Table Northwest China Hyperimmune Globulins Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Hyperimmune Globulins Sales Volume Share by Application (2018-2023)
-
Table CNBG Company Profile
-
Table CNBG Hyperimmune Globulins Revenue, Price and Gross (2018-2023)
-
Table Emergent (Cangene) Company Profile
-
Table Emergent (Cangene) Hyperimmune Globulins Revenue, Price and Gross (2018-2023)
-
Table Shanghai RAAS Company Profile
-
Table Shanghai RAAS Hyperimmune Globulins Revenue, Price and Gross (2018-2023)
-
Table Hualan Bio Company Profile
-
Table Hualan Bio Hyperimmune Globulins Revenue, Price and Gross (2018-2023)
-
Table CBPO Company Profile
-
Table CBPO Hyperimmune Globulins Revenue, Price and Gross (2018-2023)
-
Table ADMA Biologics Company Profile
-
Table ADMA Biologics Hyperimmune Globulins Revenue, Price and Gross (2018-2023)
-
Table Biotest Company Profile
-
Table Biotest Hyperimmune Globulins Revenue, Price and Gross (2018-2023)
-
Table Sichuan Yuanda Shuyang Company Profile
-
Table Sichuan Yuanda Shuyang Hyperimmune Globulins Revenue, Price and Gross (2018-2023)
-
Table CSL Behring Company Profile
-
Table CSL Behring Hyperimmune Globulins Revenue, Price and Gross (2018-2023)
-
Table Grifols Company Profile
-
Table Grifols Hyperimmune Globulins Revenue, Price and Gross (2018-2023)
-
